Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Synergy Pharmaceuticals Inc (NASDAQ:SGYP)

2.81
Delayed Data
As of Oct 20
 -0.01 / -0.35%
Today’s Change
2.56
Today|||52-Week Range
7.15
-53.86%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization56.0K120.0K163.0K233.0K
 
 
 
 
 
 
Operating ExpensesGross Income-56.0K-120.0K-163.0K-233.0K
 
 
 
 
 
General Expenses62.3M94.2M99.7M145.1M
 
 
 
 
 
Research And Development50.6M83.3M78.0M89.6M
 
 
 
 
 
Total Operating Expenses62.3M94.3M99.8M145.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-62.3M-94.3M-99.8M-145.3M
 
 
 
 
 
Extraordinary Credit149.0K1.4M0.00106.0K
 
 
 
 
Extraordinary Charge0.000.00-394.0K-40.2M
 
 
 
Interest Expense On Debt21.0K2.9M17.3M13.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-62.1M-95.8M-117.5M-198.7M
 
 
 
 
 
Income Taxes0.00-83.0K0.00-121.0K
 
 
 
Net Income-62.1M-95.7M-117.5M-198.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS85.2M94.3M105.6M164.4M
 
 
 
 
 
Shares To Calculate EPS Diluted85.2M94.3M105.6M164.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.73-$1.02-$1.11-$1.21
 
 
 
 
 
EPS Diluted-$0.73-$1.02-$1.11-$1.21